FDA Claims Short-Term Success For Pre-Market Device Reforms
This article was originally published in The Gray Sheet
Executive Summary
With many of its 510(k) and science reforms at least partially implemented, CDRH says it is seeing tangible, positive results. The device center cites a turnaround on multiple measures of review performance following the lows of 2010.